Mitchell J. Blutt MD

Filings by Mitchell J. Blutt MD span 3 companies, the busiest being Surrozen, Inc./DE, Questcor Pharmaceuticals Inc and DJ Orthopedics Inc. Over a trading history stretching from 8 May 2006 to 14 December 2022, the count stands at 55 filings.

Both buying and selling appear: 20 purchases worth €3.9M, against 15 sales worth €19.9M. The amount is not disclosed for 9 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 9 share grants and 4 option exercises. In 2022 alone, the filings show no purchases and 4 sales.

Half of the purchases are above €111k and half below.

Most recently, on 15 December 2022, the filings show an open-market sale in Surrozen, Inc./DE. The last insider purchase was made public on 4 December 2020, 2,150 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.